この記事を読む

ROS1陽性は血栓塞栓症のハイリスク群

A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer. A…

この記事を読む

標準治療後の小細胞肺癌に対するペムブロリズマブ、期待は持てそうだが…

Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From th…

この記事を読む

循環腫瘍DNAが早く消失してもアウトカムは変わらない

Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epide…

この記事を読む

KEYNOTE-189 up date

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metast…

この記事を読む

根治治療後のフォローはどうすべきか?

Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline. Schneider BJ J Clin Oncol. 2020 Mar 1…

この記事を読む

クライオバイオプシーはEGFR遺伝子変異検出に有利?

Cryobiopsy increases the EGFR detection rate in non-small cell lung cancer. Haentschel M et al. Lung Cancer. 2020 Mar;14…

この記事を読む

TKI+ベバシズマブでT790Mが減る?

Investigation of efficacy and acquired resistance for EGFR-TKI plus bevacizumab as first-line treatment in patients with…

この記事を読む

中等度以上の自然気胸でもドレナージ不要

Conservative versus Interventional Treatment for Spontaneous Pneumothorax. Brown SGA et al. N Engl J Med. 2020 Jan 30;38…

この記事を読む

ALK-TKIはPD後もプラチナ+ペメトレキセドと併用した方がよい?

Efficacy of Platinum/Pemetrexed Combination Chemotherapy in ALK-Positive NSCLC Refractory to Second-Generation ALK Inhib…

この記事を読む

多発か肺内転移かの鑑別アルゴリズム

A Novel Algorithm to Differentiate Between Multiple Primary Lung Cancers and Intrapulmonary Metastasis in Multiple Lung …